scholarly journals Age matters: collagen birefringence of superficial articular cartilage is increased in young guinea-pigs but decreased in older animals after identical physiological type of joint loading

2001 ◽  
Vol 9 (8) ◽  
pp. 694-701 ◽  
Author(s):  
M.M. Hyttinen ◽  
J.P.A. Arokoski ◽  
J.J. Parkkinen ◽  
M.J. Lammi ◽  
T. Lapveteläinen ◽  
...  
1990 ◽  
Vol 23 (12) ◽  
pp. 1239-1246 ◽  
Author(s):  
J. Jurvelin ◽  
I. Kiviranta ◽  
A.-M. Säämänen ◽  
M. Tammi ◽  
H.J. Helminen

1970 ◽  
Vol 25 (3) ◽  
pp. 184-198 ◽  
Author(s):  
R. Silberberg ◽  
W. G. Stamp ◽  
P. A. Lesker ◽  
M. Hasler

2017 ◽  
Vol 16 (6) ◽  
pp. 1971-1986 ◽  
Author(s):  
Sven Nebelung ◽  
Manuel Post ◽  
Stefan Raith ◽  
Horst Fischer ◽  
Matthias Knobe ◽  
...  

1988 ◽  
Vol 17 (3) ◽  
pp. 199-206 ◽  
Author(s):  
Markku Tammi ◽  
Ilkka Kiviranta ◽  
Leena Peltonen ◽  
Jukka Jurvelin ◽  
Heikki J. Helminen

1986 ◽  
Vol 246 (1) ◽  
pp. 33-41 ◽  
Author(s):  
Robert G. Spanheimer ◽  
Timothy A. Bird ◽  
Beverly Peterkofsky

2011 ◽  
Vol 29 (8) ◽  
pp. 1168-1177 ◽  
Author(s):  
Justin W. Fernandez ◽  
Massoud Akbarshahi ◽  
Kay M. Crossley ◽  
Kevin B. Shelburne ◽  
Marcus G. Pandy

2000 ◽  
Vol 18 (5) ◽  
pp. 245-257 ◽  
Author(s):  
Heikki J. Helminen ◽  
Mika M. Hyttinen ◽  
Mikko J. Lammi ◽  
Jari P. A. Arokoski ◽  
Tuomo Lapveteläinen ◽  
...  

2021 ◽  
Vol 23 (1) ◽  
Author(s):  
Dennis M. Minton ◽  
Christian J. Elliehausen ◽  
Martin A. Javors ◽  
Kelly S. Santangello ◽  
Adam R. Konopka

Abstract Background The objective of this study was to determine if mechanistic target of rapamycin (mTOR) inhibition with or without AMP-activated protein kinase (AMPK) activation can protect against primary, age-related OA. Design Dunkin-Hartley guinea pigs develop mild primary OA pathology by 5 months of age that progresses to moderate OA by 8 months of age. At 5 months, guinea pigs served as young control (n = 3) or were fed either a control diet (n = 8), a diet enriched with the mTOR-inhibitor rapamycin (Rap, 14 ppm, n = 8), or Rap with the AMPK-activator metformin (Rap+Met, 1000 ppm, n = 8) for 12 weeks. Knee joints were evaluated by OARSI scoring, micro-computed tomography, and immunohistochemistry. Glenohumeral articular cartilage was collected for western blotting. Results Rap- and Rap+Met-treated guinea pigs displayed lower body weight than control. Rap and Rap+Met inhibited articular cartilage mTORC1 but not mTORC2 signaling. Rap+Met, but not Rap alone, stimulated AMPK. Despite lower body weight and articular cartilage mTORC1 inhibition, Rap- and Rap+Met-treated guinea pigs had greater OA severity in the medial tibial plateau due to articular cartilage structural damage and/or proteoglycan loss. Rap and Rap+Met increased plasma glucose compared to control. Plasma glucose concentration was positively correlated with proteoglycan loss, suggesting hyperglycemic stress after Rap treatment was related to worsened OA. Conclusions This is the first study to show that Rap induced increase in plasma glucose was associated with greater OA severity. Further, articular cartilage mTORC1 inhibition and bodyweight reduction by dietary Rap and Rap+Met did not appear to protect against primary OA during the prevailing hyperglycemia.


Sign in / Sign up

Export Citation Format

Share Document